The Athlete’s Paradox: Fit Muscle, Sick Blood Work

Longevity · Masters blood work

You did five hours on the bike this week. Legs feel strong. Watts are up. Body composition looks solid. Then a routine panel comes back all green. The doctor glances at it, says it looks good for your age, and you walk out feeling confirmed.

Here’s the problem. That panel almost certainly did not include fasting insulin. And if it did, your doctor probably compared you to a reference range built from sedentary people. Being better than sedentary is not the same as being metabolically healthy.

This gap between how fit you feel and what your biomarkers actually say is not a new discovery. Researchers named it the athlete’s paradox decades ago. It still catches trained men off guard.

Your legs can be insulin sensitive while your fasting insulin tells a different story. Only one of those shows up on a lab report.

What the athlete’s paradox actually means

The original observation was this: endurance-trained skeletal muscle is packed with intramuscular triglycerides, which in any other context would be a warning. In sedentary or obese people, elevated intramuscular lipid tracks with insulin resistance. It’s one of the mechanisms behind type 2 diabetes.

In trained muscle, the opposite holds. High intramuscular lipid sits next to high oxidative capacity and high insulin sensitivity. The muscle adapted to burn fat as a primary fuel. It stores fat to burn it, not because it can’t clear glucose. That is metabolic flexibility doing its job.

The good version of the story ends there. Well-trained muscle is a metabolic asset. The trap is assuming that asset covers the rest of your biology.

It does not.

The part nobody tells you

Skeletal muscle is not the only tissue that matters for insulin sensitivity. Your liver, your adipose tissue, and your pancreatic beta cells all have their own insulin dynamics. You can have well-adapted muscle while your liver runs low-grade insulin resistance driven by how you eat. Your blood work will not clearly separate those two things unless someone knows to look.

Fasting insulin is the early signal. Well before fasting glucose moves, well before HbA1c changes, fasting insulin starts climbing as your pancreas compensates for tissue-level resistance. A fasting insulin of 10 is not alarming by most lab standards. Most labs flag anything under 25 as normal. Optimal, based on research into actual metabolic outcomes, sits closer to 5 or below.

That target is not an athlete’s target. It is the correct target for everyone.

The current reference ranges are wrong. They were built from population averages that include a large share of metabolically unhealthy people. A range anchored to “normal for a sedentary, overfed population” is not a health standard. It is a description of how sick the average person is. Fasting insulin below 5 is what a metabolically healthy person looks like, whether they ride bikes or not.

Why this test costs $14 and your doctor never ordered it

Fasting insulin detects metabolic disease 10-15 years before it shows up in fasting glucose or HbA1c. Glucose is volatile. A single reading tells you very little. HbA1c is a 90-day average of red blood cell glycation. By the time either of those numbers moves, the problem has been running for years.

Fasting insulin catches it early. It is a direct window into how hard your pancreas is working to keep glucose in range. A rising fasting insulin, still well inside “normal” lab limits, tells you insulin resistance is developing somewhere in the system. That is the signal. Everything else comes later.

So why has this test been absent from routine labs for so long? There is no medication tied to a high fasting insulin result. No pharmaceutical protocol kicks in at a reading of 12. Because there is no next step a drug can address, there has been no financial incentive to test for it. The test costs roughly $14. The intervention it points toward is dietary. That combination, a cheap test with a lifestyle answer, has kept it off the standard panel for decades.

That is changing, partly because metabolic health research is getting more attention and partly because patients are asking for it. You still have to ask specifically. It is not on a standard metabolic panel by default.

Why masters riders are specifically vulnerable

The athlete’s paradox is most pronounced in endurance-trained people, which means masters cyclists sit right in the middle of it. You have the adaptation. You have the intramuscular lipid stores and the oxidative capacity to burn them. That adaptation can mask early metabolic dysfunction in the conventional numbers a physician reviews.

Compounding this: masters riders often have decades of eating habits built around training volume, not metabolic health. High training weeks justify high carbohydrate intake. Carbs fuel performance, so the logic feels solid. The problem is the off-bike pattern. Recovery meals. Weekend eating. The total context of what goes in shapes the metabolic environment training operates inside.

If you are riding 8-10 hours a week and eating in a way that keeps fasting insulin elevated, you are building a gap between your performance physiology and your longevity physiology. Those two things can diverge hard in your 50s and 60s, and the split tends to show up suddenly rather than gradually.

What the Rollfast Longevity Audit targets

The Rollfast Longevity Audit does not accept “in range” as the goal. For fasting insulin, the target is under 5, for athletes and non-athletes alike. For high-sensitivity CRP (systemic inflammation), the target is under 1 mg/L. For fasting glucose, under 90 is a better functional target than anything under 100. These are not extreme positions. They are what the research on metabolic flexibility and long-term health outcomes actually supports.

The reason these numbers matter more than a physician’s green checkmark is simple. Labs set reference ranges from large population samples that include a lot of metabolically unhealthy people. Being within one standard deviation of a sedentary, overfed reference population is not a fitness goal. It is a floor, not a ceiling.

Your training earns you a higher standard, and it creates a higher obligation to meet it. You are stressing your cardiovascular system in ways sedentary people never do. That stress, applied consistently over decades, is beneficial. It also means your body needs metabolic capacity that can recover from it, adapt to it, and not accumulate inflammatory burden from it.

Riding more does not fix what you are eating

This is the part that pushes back against a deeply held belief in endurance culture: volume is not a metabolic cure.

Plenty of masters riders treat training hours as a buffer. If the eating gets sloppy during a high-stress week, the rides compensate. If the weight creeps up, a big training block will handle it. This logic has enough truth in it to feel convincing, and enough error in it to cause real damage over time.

The metabolic housekeeping that determines your blood work, your inflammatory status, and your long-term cardiovascular and cognitive risk happens largely in the kitchen, not on the road. That is the same argument behind real food over gel culture: what you eat off the bike is the other half of the work.

The practical intervention

If you have not had a fasting insulin drawn recently, get one. Ask specifically. It is typically not included in a standard metabolic panel. Pair it with high-sensitivity CRP and a fasting lipid panel that includes triglycerides and HDL. The triglyceride-to-HDL ratio is a useful insulin sensitivity proxy, with under 1.5 a reasonable target.

When you get the results, evaluate them against optimal ranges, not just lab reference ranges. If fasting insulin is above 5, the intervention is dietary, not another training block.

On the dietary side, the Rollfast Formula One Nutrition framework applies directly. Protein first, 1.5 grams per pound of bodyweight per day, with servings large enough to clear the 50-gram synthesis threshold at each main meal. Fat second, from quality sources. Carbohydrates last, earned by training load, and timed around efforts rather than scattered across the day. This structure pulls carbohydrate exposure down without obsessive tracking, keeps insulin activity lower across the day, and preserves the muscle protein synthetic signal that matters for masters athletes.

The training stays. The volume is not the problem. The assumption that training earns you a free pass on the metabolic side is the assumption that gets riders in trouble at 60, when the fasting insulin that sat at 10 for a decade has finally pulled glucose up with it, or the low-grade CRP nobody flagged turns out to have been quietly damaging endothelium the whole time.

Fit muscle and sick blood work can coexist. The athlete’s paradox is real, it is well-documented, and it is specifically relevant to endurance-trained men in their 40s and 50s. Your training creates an adaptation that can partially obscure metabolic dysfunction in conventional labs, which means you need better markers, with better targets, and you cannot assume training volume is doing metabolic work it was never designed to do.

Fasting insulin below 5 is not an athlete standard. It is a human standard. The reference ranges that say otherwise are not protecting you. They are describing how sick average has become.

The athletes who stay sharp at 65 are not just the ones who kept riding. They are the ones who kept riding and kept the metabolic infrastructure in good repair alongside it.

Volume is not a metabolic cure.